Invesco Russell 1000 Quality Factor ETF
OQAL
Chicago Board Options Exchange- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- IPO Date
- Nov 8, 2017
- CIK
- 0001384032
- Similar Companies
- Business
- Invesco Russell 1000 Quality Factor ETF (OQAL) is an exchange-traded fund that seeks to track the investment results, before fees and expenses, of the Russell 1000 Quality Factor Index, which focuses on large-cap U.S. equities exhibiting quality characteristics such as high profitability, stable earnings growth, and low debt levels. The ETF holds approximately 396 securities, with roughly 36% of assets concentrated in its top 10 holdings, primarily spanning sectors like technology, healthcare, and consumer goods; it maintains a net expense ratio of 0.19% and targets developed North American markets. Issued by Invesco Ltd. through Invesco Exchange-Traded Fund Trust, OQAL was incepted on November 8, 2017, and is managed from headquarters in Downers Grove, Illinois. The fund provides investors with exposure to a diversified portfolio of Russell 1000 constituents selected and weighted by quality factor metrics; it distributes dividends quarterly, with a reported annual yield around 1.5%, and emphasizes large-cap stocks comprising the majority of its assets under management, currently valued at approximately $5.68 million. OQAL trades on the BATS exchange under the ticker OQAL, with key fund managers including Frank Vallario and Donal Bishnoi; it operates as a regulated investment company without K-1 distributions. In recent developments, the ETF's issuer Invesco has pursued structural enhancements across its ETF platform, including a July 2025 shareholder proposal to reclassify the Invesco QQQ Trust from a unit investment trust to an open-end fund structure, enabling greater operational flexibility, securities lending, and fee revenue generation while reducing expense ratios. Invesco expanded its active ETF lineup to 31 products by mid-2025, launched new offerings such as the Invesco India Consumption Fund in October 2025 and the Invesco Emerging Markets Enhanced Equity UCITS ETF in September 2025, and deepened thematic partnerships with Nasdaq for sector-specific ETFs like the Invesco Nasdaq Biotechnology ETF (IBBQ). Additionally, Invesco secured regulatory approvals in 2025 for a 60% stake transfer in its Indian mutual fund arm to IIHL, supporting expanded distribution across 40 cities and AUM growth to over ₹85,393 crore.